Introduction

S
leep disturbances and fatigue are common conditions in the working population and are important health problems. Sleep disturbances are prospectively associated with a wide range of diseases, such as heart disease and diabetes [1] [2] [3] and have been found to be both a precursor and a consequence of depression. [4] [5] [6] Fatigue is a common complaint and associated with chronic diseases and psychological ill-health. [7] [8] [9] [10] Although several studies have shown that sleep disturbances and fatigue are associated with sickness absence and work disability, [11] [12] [13] [14] [15] [16] [17] only a few studies have prospectively examined the independent effect of sleep disturbances and fatigue on sickness absence-while adjusting for depressive symptoms. Though different definitions and measurements of predictors and outcomes, different social security settings, and different response rates hamper a direct comparison of results, several prospective studies showed that either sleep disturbances or fatigue were related to the onset of sickness absence. Vathera et al. 15 found that disturbed sleep was associated with a higher rate of subsequent sickness absence after family death or illness, also, when adjusted for psychological distress, anxiety and lifetime depression. Likewise, a Norwegian study showed that sleep problems, after adjustment for health, behavioural and work-related factors, predicted sickness absence at follow-up. 18 In another study by Eriksen et al., sleep complaints did not increase the risk of sickness absence, while fatigue did. 19 Recently, Siversten et al. 20 found insomnia to be a strong independent predictor of sickness absence, after adjustment for a broad range of confounders, including physical and mental symptoms, and conditions and socio-demographics.
For fatigue, an increased risk of both short-and long-term sickness absence was shown after adjustment for socio-demographic and work-related confounders. 17 Another study found that fatigue was associated with the onset of long-term sickness absence in men only. 16 After adjustment for the presence of a chronic disease, the effect was attenuated and no longer statistically significant. These studies did not adjust for depressive symptoms or sleep disturbances.
Only Sleep disturbances and fatiguemanagement of sickness absence, it is important to explore whether these conditions can be distinguished from each other.
Hence, the objectives of this study are (i) to examine whether sleep disturbances and fatigue are independently related to the onset of register-based sickness absence of !3 weeks during a 1-year follow-up in a representative sample of the Danish workforce, while also adjusting for depressive symptoms and (ii) to determine if possible associations are gender specific.
Methods
Study design and sample
This prospective study is based on baseline survey data from the Danish Work Environment Cohort Study (DWECS) 21 in 2005 and on data of registered sickness absence of !3 weeks during a 1-year period from the Danish National Register of Social Transfer Payments (DREAM). 22 Records were linked using the participants' personal identification numbers from the Central Population Register. Full details of DWECS have been reported elsewhere. 21, 23 In Data were collected by telephone interview, self-administered paper or Internet questionnaire. Among the participants, 8427 were employees. Participants in job training (n = 596), employed under special working conditions (e.g. modified duty due to illness; n = 256), on sick-leave at baseline (n = 114), with a sickness absence period of !3 weeks during the last 3 months (n = 255) or with missing values on any variable used in the analyses (n = 668) were excluded. The final study sample consisted of 6538 employees, 3178 men (49%) and 3360 women (51%). The mean ages were 42.4 (SD 10.5) for men and 42.8 (SD 10.5) for women.
Measures
Sickness absence
The cumulative incidence of a sickness absence episode of !3 weeks during a 1-year follow-up was obtained from DREAM, which contains weekly updated information on all public transfer payments, including sickness absence compensation. The compensations is paid from the municipalities to the employers, usually after three weeks of sickness absence (before June 2008: after two weeks of sickness absence). However, sickness absence compensation from the municipalities can be paid from the first day of sickness absence when the sick-listed employee is (i) registered with a chronic disease or (ii) employed in a small private company with a special state-run insurance policy. A more detailed description of DREAM has been published elsewhere. 22 DREAM data were available for all participants.
Sleep disturbances
Sleep disturbances at baseline were measured with four items: two items have been adapted from the Karolinska Sleep Questionnaire 26 in consultation with Akerstedt, the other two items and the response categories have been derived from preparatory work for the Short Form(SF)-36. 27 Participants were asked to rate the amount of time during the past four weeks they (i) had difficulties falling asleep, (ii) woke up and had difficulties falling asleep again, when they should have been sleeping, (iii) slept poorly or restlessly and (iv) woke up too early and were unable to fall asleep again. Response categories were: (i) 'none of the time'; (ii) 'a little of the time'; (iii) 'some of the time'; (iv) 'a good part of the time'; (v) 'most of the time'; and (vi) 'all of the time'. The scores for the four questions were added up, resulting in a sum score ranging from 4 to 24 points, with higher scores indicating more sleep disturbances. The Cronbach's was 0.88.
Fatigue
Fatigue at baseline was assessed with the Danish version of the 4-item vitality scale, a subscale of the SF-36. 28, 29 The vitality scale is meant to measure fatigue and energy level. Participants were instructed to indicate the amount of time during the past four weeks they (i) felt full of life, (ii) had a lot of energy, (iii) felt worn out and (iv) felt tired. The response options for each item were identical with the above-described sleep disturbance scale. After items c and d were reversed, the responses to the individual items were added up, resulting in a sum score ranging from 4 to 24, with higher scores indicating more fatigue.
Covariates
In DWECS 2005, employees provided information on age, cohabitation, children below 3 years and occupational grade. Occupational grade was defined based on employment grade, job title and education: (I. Executives and/or having a university degree; II. Middle managers and/or having >3-4 years of vocational education; III. Other white-collar workers; IV. Skilled blue-collar workers; V. Semi-or unskilled blue-collar workers). Smoking was categorized into 'current smokers' vs. 'current non-smokers'. Alcohol consumption was dichotomized in 'no or moderate consumption' vs. 'heavy consumption', with heavy consumption defined as drinking more than two (women) and three (men) units per day, respectively. A unit was defined as one small bottle of beer (33 cl), one glass of wine or one shot of liquor. Leisure-time physical activity was assessed with 'When you describe your leisuretime physical activity in the past year, including commuting to or from work, to what group do you belong?' with four response categories; sedentary, light, moderate and strenuous physical activity. The body mass index (BMI) was calculated from self-reported information on weight and height and categorized into 'underweight' (BMI <18.5), 'normal weight' (BMI 18.5-24.9), 'overweight' (25-29.9) and 'obese' (!30). The presence of a doctor-diagnosed disease was measured by a list of severe health problems (e.g. cardiovascular disease, cancer, diabetes, psychological disorders) and asking the participants to indicate whether a physician had ever told them that they had one of these health problems. Participants who indicated at least one of the health problems were categorized as having a doctor-diagnosed disease. Depressive symptoms were measured with the 5-item Mental Health Inventory, a subscale of the SF-36. 28, 29 Although originally constructed as a scale to measure mental health, in general, several studies have shown that the scale has a high validity for assessing depressive symptoms. [30] [31] [32] To control for the effects of survey method, a variable was included indicating by which method (telephone interview, paper or Internet questionnaire) data were collected. 33 
Statistical analysis
Pearson's correlations were calculated for sleep disturbances and fatigue in men and women. The prospective associations between baseline sleep disturbances and fatigue and the onset of a sickness absence spell of !3 weeks during 1-year follow-up were analysed with Cox proportional hazard models. Possible violations of the proportional hazard assumptions were analysed by Schoenfeld residuals. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated per standard deviation increase in sleep disturbances and fatigue, and adjusted for gender, age, cohabitation, children below 3 years, occupational grade, data collection method, health behaviours and self-reported doctor-diagnosed disease (Model 1). HRs were further adjusted for depressive symptoms (Model 2). Finally effects of fatigue and sleep disturbances were mutually adjusted (Model 3). Participants were followed until onset of sickness absence of !3 weeks, emigration, death or end of follow-up, whichever came first. Analyses were conducted for the total sample and for men and women separately. Data were analysed using STATA, version 8.
Ethics
The study has been notified to and registered by the Danish Data Protection Agency (Datatilsynet, see http://www.datatilsynet.dk/ english for details). Danish questionnaire-and register-based studies do not require approval from the Danish National Committee on Biomedical Research Ethics (Den Centrale Videnskabsetiske Komité, see http://cvk.im.dk/cvk/site.aspx?p=119 for details).
Results
Sleep disturbances, fatigue and sickness absence
Sleep disturbances and fatigue were moderately correlated, in both men (r = 0.40) and women (r = 0.35). The cumulative incidence for the onset of sickness absence of !3 weeks during the 1-year follow-up was 5.6% (n = 368), 4.2% (n = 133) in men and 7.0% (n = 235) in women. Table 1 shows the study population characteristics and the incidence of sickness absence. Table 2 shows the prospective associations between baseline sleep disturbances and the risk of sickness absence during follow-up. In the total sample, a 1 SD increase of the sleep disturbance scale predicted a 10% increased risk in sickness absence (HR = 1.10, 95% CI 1.01-1.21) after adjustment for covariates (Model 1). When additionally adjusted for depressive symptoms at baseline, the effect of sleep disturbances was attenuated and lost statistical significance (Model 2). Further adjustment for fatigue at baseline (Model 3) did not change results substantially. Gender-stratified analyses showed similar results. When we tested for a multiplicative interaction effect of gender and sleep disturbances on risk of sickness absence, we found P-values of 0.98 (crude analysis) and 0.99 (adjusted for covariates in Model 3), respectively. Proportional hazard assumption was fulfilled in all models. Table 3 shows the prospective associations between baseline fatigue and the risk of sickness absence during 1-year follow-up. In the total study sample, a 1 SD increase in fatigue predicted a 16% increased risk of sickness absence (HR = 1.16, 95 CI = 1.05-1.28) after adjustment for covariates (Model 1). When additionally adjusted for depressive symptoms at baseline, the effect of fatigue was attenuated and lost statistical significance (Model 2). Further adjustment for fatigue at baseline (Model 3) did not change results substantially. Gender-stratified analyses showed marked different results for men and women. Among men, the effect of fatigue on sickness absence was substantially stronger than among women, and remained statistically significant in all three models. In Model 3, fatigue among men predicted a 25% increased risk of sickness absence (HR = 1.25, 95% CI 1.00-1.56). When we tested for a multiplicative interaction effect of gender and fatigue on risk of sickness absence we found P-values of 0.24 (crude analysis) and 0.19 (adjusted for covariates in Model 3), respectively. Proportional hazard assumption was fulfilled in all models.
Post hoc analysis
Because of the gender-specific effect of fatigue on sickness absence, and the more pronounced attenuation of the effect size when adjusting for baseline depressive symptoms among women, we wondered whether the association between baseline fatigue and depressive symptoms might have been considerably stronger among women compared with men. However, when we calculated post hoc gender-stratified correlations between fatigue and depressive symptoms at baseline, we found similar high correlations in the two genders. The correlation coefficients were r = 0.65 among men and r = 0.70 among women.
Discussion
The present study prospectively investigated the independent associations between sleep disturbances, fatigue and subsequent sickness absence in both genders, while accounting for depressive symptoms.
The main finding of this study is that in the total study sample, both sleep disturbances and fatigue predicted the onset of sickness absence, when adjusted for a wide range of covariates, but both were no longer predictive when adjusted for depressive symptoms at baseline. Fatigue remained a strong and statistically significant predictor of sickness absence even after adjustment for depressive symptoms and sleep disturbances in men, but not in women.
That the effect of sleep disturbances was greatly attenuated after adjustment for depressive symptoms is not surprising. Sleep disturbances are closely related to depressive symptoms as sleep disturbances are both a precursor and a symptom of depression. [4] [5] [6] As delineated in the introduction, a Swedish study has found a prospective effect of sleep disturbances on intermediate and long-term sickness absence. 12 However, this study did not adjust for depressive symptoms or the presence of disease.
Fatigue was shown to be a strong, independent predictor of sickness absence in men, but not in women. The null finding for women is in line with earlier results from a Dutch study, which showed that 'being a case of prolonged fatigue' did not predict the onset of sickness absence (!42 consecutive days) among women. 16 In the above-mentioned Swedish study, 12 fatigue was prospectively related to intermediate sickness absence (14-89 days) in women and to long-term sickness absence (!90 days) in both genders. These associations, however, were not adjusted for depressive symptoms or the presence of disease. When we tested for multiplicative interaction, the fatigue Â gender interaction was not statistically significant. However, investigating interactions requires large study samples and it is possible that our study lacked the statistical power for detecting an interaction. Given the marked differences between men and women in the HRs, it is reasonable to consider that the effect of fatigue on risk of sickness absence may be modified by gender, even though the statistical testing of interaction was not significant.
An explanation for the stronger effect of fatigue among men could be that men more often than women work in jobs that are incompatible with increased fatigue levels. Hence, men might more often than women face demands in their jobs that cannot be dealt with, if fatigue levels are above a certain point. Another explanation could be that women are more successful in coping with fatigue so that fatigue has a smaller effect on their work ability than among men. For example, it is well-known that women more frequently see their general practitioners than men. If early signs of fatigue cause women, but not men, to see their general practitioner, women might have a higher chance of getting early treatment and preventing further deterioration of health and subsequent sickness absence. It is also possible that fatigue in men is different than in women. It has been argued that among men reasons for fatigue might be more physical, whereas among women reasons might include more psychosocial factors. 34 If this is true, the adjustment for depressive symptoms in the present study would, to a larger extent, have attenuated fatigue among women than among men. However, when we investigated the baseline correlation between fatigue and depressive symptoms, we found very similar high correlations for both men and women.
When studying the consequences of fatigue in terms of sickness absence in the working population, other, probably related, conditions such as burnout have to be acknowledged. Although the literature suggests that there is a considerable overlap between the main symptoms of exhaustion and subjective fatigue, fatigue and burnout also occurred separately from each other. 35 It was also demonstrated that pure fatigue seemed to be more associated with health-related factors, whereas pure burnout seemed to be more associated with work-related factors. 35 Research findings also suggest that fatigue and burnout influence each other in time. 36 As for the present study, it remains unclear why the relationship between fatigue and sickness absence is stronger among men than among women. To further elucidate the temporal relationships between sleep disturbances, fatigue, depressive symptoms and sickness absence and to disentangle mediators from confounders, studies with repeated measurements of all measures during a longer follow-up period are warranted.
11,15
Strengths and limitations
The study's strengths are the prospective design, the representative sample of the Danish employed workforce, and the record linkage with administrative sickness absence data. The prospective design helps to establish a temporal sequence between exposure and outcome; the use of the representative samples for generalizing the findings to the Danish workforce. The record linkage of the cohort data with objective sickness absence data from a national register is another advantage of this study. Moreover, all analyses were conducted for the total sample and stratified by gender, which provides insight in differential, i.e. gender-specific, effects of sleep disturbances and fatigue on sickness absence. In contrast to previous studies, 12 all analyses were adjusted for a broad range of potentially confounding factors, such as indicators of health (i.e. self-reported doctor-diagnosed disease and depressive symptoms) and health behaviour (i.e. smoking, alcohol consumption, leisure-time physical activity, BMI).
A limitation of the study is the absence of an established measure for sleep disturbances. In contrast to the single-item measure used by Akerstedt et al., 12 the measure was based on items adapted from the Karolinska Sleep Questionnaire 26 though slightly differently phrased. Fatigue was assessed with the Danish version of the SF-36 vitality scale. Further research is needed to elaborate on these measures of sleep disturbances and fatigue-also in relation to other conditions such as burnout or anxiety, for which no data were available in the present study. With respect to the outcome measure, registered sickness absence, it has to be acknowledged that DREAM does not contain diagnosis information because it is not required to report a diagnosis of sickness absence, i.e. the outcome concerns 'sickness absence due to any cause'. It is important to note, however, that DREAM has been deemed sufficiently accurate for register-based follow-up of social and economic consequences of disease. 22 
Conclusion
After adjustment for depressive symptoms, sleep disturbances were not related to the risk of future sickness absence. In men, but not in women, fatigue predicted the risk of sickness absence, even after depressive symptoms and sleep disturbances were taken into account. Further prospective studies in other populations are recommended to explore the pathways from fatigue to sickness absence in more detail, thereby also addressing the differential effects in men and women. To further elucidate the temporal relationships between sleep disturbances, fatigue, depressive symptoms and sickness absence, studies with repeated measurements of all measures during a longer follow-up period are needed. In all-and in view of the high social and economic cost implications of sickness absence-the early detection and treatment of fatigue in men should be high on the stakeholders' agenda. 
Key points
Sleep disturbances in both genders and fatigue in women were not associated with future sickness absence after depressive symptoms were taken into account. In men, fatigue predicted the risk of future sickness absence even after depressive symptoms and sleep disturbances were taken into account. In view of the high social and economic cost implications of sickness absence, the early detection and treatment of fatigue in men should be high on the stakeholders' agenda.
